56 related articles for article (PubMed ID: 26418254)
1. The mechanism of radiosensitization by YM155, a novel small molecule inhibitor of survivin expression, is associated with DNA damage repair.
Hu S; Fu S; Xu X; Chen L; Xu J; Li B; Qu Y; Yu H; Lu S; Li W
Cell Physiol Biochem; 2015; 37(3):1219-30. PubMed ID: 26418254
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of DNA‑PK activity sensitizes A549 cells to X‑ray irradiation by inducing the ATM‑dependent DNA damage response.
Yang L; Yang X; Tang Y; Zhang D; Zhu L; Wang S; Wang B; Ma T
Mol Med Rep; 2018 Jun; 17(6):7545-7552. PubMed ID: 29620203
[TBL] [Abstract][Full Text] [Related]
3. USP14 Regulates DNA Damage Response and Is a Target for Radiosensitization in Non-Small Cell Lung Cancer.
Sharma A; Almasan A
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887472
[TBL] [Abstract][Full Text] [Related]
4. MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer.
Ramesh S; Cifci A; Javeri S; Minne RL; Longhurst CA; Nickel KP; Kimple RJ; Baschnagel AM
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1379-1390. PubMed ID: 37979706
[TBL] [Abstract][Full Text] [Related]
5. Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a.
Lucchesi CA; Zhang J; Ma B; Nussinov R; Chen X
Cancer Res; 2021 Apr; 81(7):1827-1839. PubMed ID: 33472892
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel assay to identify radiosensitizers that target nucleophosmin 1.
Penthala NR; Crooks PA; Freeman ML; Sekhar KR
Bioorg Med Chem; 2015 Jul; 23(13):3681-6. PubMed ID: 25922180
[TBL] [Abstract][Full Text] [Related]
7. Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response.
Mazzio EA; Lewis CA; Elhag R; Soliman KF
Cancer Genomics Proteomics; 2018; 15(4):249-264. PubMed ID: 29976630
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin treatment varies the radiation response of human breast cells in 2D or 3D culture.
Manda K; Juerß D; Fischer P; Schröder A; Koenen A; Hildebrandt G
Invest New Drugs; 2021 Jun; 39(3):658-669. PubMed ID: 33313978
[TBL] [Abstract][Full Text] [Related]
9. Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe.
Rachamala HK; Madamsetty VS; Angom RS; Nakka NM; Kumar Dutta S; Wang E; Mukhopadhyay D; Pal K
Res Sq; 2023 Dec; ():. PubMed ID: 38196607
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of demethylase by IOX1 modulates chromatin accessibility to enhance NSCLC radiation sensitivity through attenuated PIF1.
Li Q; Qin K; Tian Y; Chen B; Zhao G; Xu S; Wu L
Cell Death Dis; 2023 Dec; 14(12):817. PubMed ID: 38086789
[TBL] [Abstract][Full Text] [Related]
11. A Novel Interaction of Slug (SNAI2) and Nuclear Actin.
Zhuo L; Stöckl JB; Fröhlich T; Moser S; Vollmar AM; Zahler S
Cells; 2024 Apr; 13(8):. PubMed ID: 38667311
[TBL] [Abstract][Full Text] [Related]
12. MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer.
Ramesh S; Cifci A; Javeri S; Minne R; Longhurst CA; Nickel KP; Kimple RJ; Baschnagel AM
bioRxiv; 2023 Oct; ():. PubMed ID: 37961176
[TBL] [Abstract][Full Text] [Related]
13. COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic Target.
Suraweera A; Duijf PHG; Jekimovs C; Schrobback K; Liu C; Adams MN; O'Byrne KJ; Richard DJ
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669398
[TBL] [Abstract][Full Text] [Related]
14. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
Bol GM; Vesuna F; Xie M; Zeng J; Aziz K; Gandhi N; Levine A; Irving A; Korz D; Tantravedi S; Heerma van Voss MR; Gabrielson K; Bordt EA; Polster BM; Cope L; van der Groep P; Kondaskar A; Rudek MA; Hosmane RS; van der Wall E; van Diest PJ; Tran PT; Raman V
EMBO Mol Med; 2015 May; 7(5):648-69. PubMed ID: 25820276
[TBL] [Abstract][Full Text] [Related]
15. Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.
Cui Q; Huang C; Liu JY; Zhang JT
J Med Chem; 2023 Dec; 66(24):16515-16545. PubMed ID: 38092421
[TBL] [Abstract][Full Text] [Related]
16. Germline specific genes increase DNA double-strand break repair and radioresistance in lung adenocarcinoma cells.
Liu W; Bruggeman JW; Lei Q; van Pelt AMM; Koster J; Hamer G
Cell Death Dis; 2024 Jan; 15(1):38. PubMed ID: 38216586
[TBL] [Abstract][Full Text] [Related]
17.
Haider S; Chakraborty S; Chowdhury G; Chakrabarty A
ACS Pharmacol Transl Sci; 2024 May; 7(5):1237-1251. PubMed ID: 38751638
[TBL] [Abstract][Full Text] [Related]
18. The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cells.
Lu M; Gao Q; Jin R; Gu M; Wang Z; Li X; Li W; Wang J; Ma T
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38498096
[TBL] [Abstract][Full Text] [Related]
19. Thermal proteome profiling reveals insight to antiproliferative and pro-apoptotic effects of Lagunamide A in the modulation of DNA damage repair.
Hu Y; Mostert D; Orgler C; Andler O; Zischka H; Kazmaier U; Vollmar A; Braig S; Sieber S; Zahler S
Chembiochem; 2024 May; ():e202400024. PubMed ID: 38716781
[TBL] [Abstract][Full Text] [Related]
20. YM155 Induces DNA Damage and Cell Death in Anaplastic Thyroid Cancer Cells by Inhibiting DNA Topoisomerase IIα at the ATP-Binding Site.
Mackay RP; Weinberger PM; Copland JA; Mahdavian E; Xu Q
Mol Cancer Ther; 2022 Jun; 21(6):925-935. PubMed ID: 35405742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
